Clin2
NCT05713877Possibly a fitRecruiting

Melatonin to treat confusion in ICU patients

Delirium

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This Phase 2 trial tests whether melatonin can reduce delirium, a sudden confusion that can happen in the ICU. If you qualify, you may be given melatonin to see if it improves alertness and comfort during an expected longer ICU stay.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and admitted to the intensive care unit (ICU)
  • Your care team expects you will stay in the ICU for more than 48 hours
  • You have signs of ICU delirium, with an ICDSC score of 4 or higher within the last 48 hours
  • You have not taken melatonin in the past 24 hours
  • You do not have allergy or known sensitivity to melatonin or the study medicine ingredients
  • You are not pregnant or breastfeeding, and you can use enteral medicines (through a tube or by mouth)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06509191Recruiting· Phase 2/Phase 3
Melatonin for preventing delirium in older hospital patients

This trial tests if giving melatonin (a natural sleep hormone) can help prevent delirium (sudden confusion) in older adults who are hospitalized. It may help you if you are 65 or older and admitted to the hospital for general medical care.

Muscat
NCT07407400Recruiting· Phase 4
Sleep medication to prevent confusion in older ICU patients

This study tests whether a sleep medication called lemborexant can help older patients in the ICU sleep better and prevent post-surgery confusion. It may be a good fit if you are over 65 and will be in the ICU for at least two days after surgery.

Bangkok
NCT06824077Not yet recruiting· Early Phase 1
Improving sleep in the intensive care unit with a relaxation medicine

This study tests whether giving a medicine called dexmedetomidine (which helps people relax and sleep) as part of a sleep-promoting routine can reduce confusion and delirium in the intensive care unit (ICU). It may help you sleep better and recover more smoothly.

NCT06993194Not yet recruiting
Comparing two medicines for calming ICU patients with brain injury

This study tests two medications, haloperidol and dexmedetomidine, to see which works better for reducing confusion and agitation in patients who are on a breathing machine after a traumatic brain injury. If you or a loved one is in the ICU with a brain injury and is restless or confused, this trial may help find better ways to manage those symptoms.

NCT07369258Recruiting
Music to prevent confusion in the ICU for older adults

This trial tests whether listening to music can help prevent delirium (sudden confusion) in older patients in the intensive care unit. If it works, it could offer a simple, drug-free way to protect your thinking during a hospital stay.

Buenos Aires, Buenos Aires F.D.
NCT05525702Recruiting
VR sessions to lower confusion in ICU patients

This trial tests whether virtual reality (VR) activities can reduce delirium—new, sudden confusion—in people staying in the ICU. It may help patients feel clearer and more oriented during a longer ICU stay.

Beijing, Beijing Municipality

Hear when a new Delirium trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.